ArticleEmerging microbes & infections2024
Viral genetics and transmission dynamics in the second wave of mpox outbreak in Portugal and forecasting public health scenarios.
Abstract read
In one paragraph
Article in Emerging microbes & infections, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Dynamics of global mpox epidemics, 1970-2025: a systematic review and meta-analysis of evolving transmissibility and intervention effects.BMJ global health · 2026Pooled it
- Undetected circulation of monkeypox virus in Portugal: Evidence for a 50-day gap before first detection.Global epidemiology · 2026Article
- Assessment of knowledge and use of HIV primary and secondary prevention strategies in Portugal: a scoping review.BMC public health · 2026Article
- Public health surveillance and outbreak preparedness for mpox.Current opinion in HIV and AIDS · 2026Review
- Behavior change and infection induced immunity led to the decline of the 2022 Mpox outbreak in Berlin.Communications medicine · 2026Article
- Mpox Surveillance and Laboratory Response in Portugal: Lessons Learned from Three Outbreak Waves (2022-2025).Infectious disease reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
46 authors.
Rita CordeiroEmergency Response and Biopreparedness Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
Constantino P CaetanoDepartment of Epidemiology, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
Daniel SobralGenomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
Rita FerreiraGenomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
Luís CoelhoGenomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
Ana PeleritoEmergency Response and Biopreparedness Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
Isabel Lopes de CarvalhoEmergency Response and Biopreparedness Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
Sónia NamoradoDepartment of Epidemiology, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
Dinis B LoyensDepartment of Epidemiology, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
Ricardo MexiaDepartment of Epidemiology, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
Cândida FernandesServiço de Dermatovenereologia, Consulta de DST, Unidade Local de Saúde de São José, Lisbon, Portugal.
José Miguel NevesServiço de Dermatovenereologia, Consulta de DST, Unidade Local de Saúde de São José, Lisbon, Portugal.
Ana Luísa JoãoServiço de Dermatovenereologia, Consulta de DST, Unidade Local de Saúde de São José, Lisbon, Portugal.
Miguel RochaGAT - Grupo de Ativistas em Tratamentos, GAT-CheckpointLX, Lisbon, Portugal.
Luís Miguel DuqueGAT - Grupo de Ativistas em Tratamentos, GAT-CheckpointLX, Lisbon, Portugal.
Inês CorreiaGAT - Grupo de Ativistas em Tratamentos, GAT-Intendente, Lisbon, Portugal.
Teresa BaptistaGAT - Grupo de Ativistas em Tratamentos, GAT-Intendente, Lisbon, Portugal.
Cláudia BrazãoDermatology Department, Unidade Local de Saúde de Santa Maria, Lisbon, Portugal.
Diogo SousaDermatology Department, Unidade Local de Saúde de Santa Maria, Lisbon, Portugal.
Paulo FilipeDermatology Department, Unidade Local de Saúde de Santa Maria, Lisbon, Portugal.
Miguel AlpalhãoDermatology Department, Unidade Local de Saúde de Santa Maria, Lisbon, Portugal.
Fernando MaltezInstitute of Environmental Health, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
Diana PóvoasServiço de Doenças Infeciosas, Hospital de Curry Cabral, Unidade Local de Saúde de São José, Lisbon, Portugal.
Raquel PintoServiço de Doenças Infeciosas, Hospital de Curry Cabral, Unidade Local de Saúde de São José, Lisbon, Portugal.
João CariaServiço de Doenças Infeciosas, Hospital de Curry Cabral, Unidade Local de Saúde de São José, Lisbon, Portugal.
Rita Patrocínio de JesusServiço de Infeciologia, Hospital Professor Doutor Fernando Fonseca, Unidade Local de Saúde Amadora/Sintra, Amadora, Portugal.
Patrícia PachecoServiço de Infeciologia, Hospital Professor Doutor Fernando Fonseca, Unidade Local de Saúde Amadora/Sintra, Amadora, Portugal.
Francesca PeruzzuServiço de Infeciologia, Hospital Professor Doutor Fernando Fonseca, Unidade Local de Saúde Amadora/Sintra, Amadora, Portugal.
Josefina MéndezServiço de Doenças Infecciosas, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
Luís FerreiraServiço de Doenças Infecciosas, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
Kamal MansinhoServiço de Doenças Infecciosas e Medicina Tropical, Hospital de Egas Moniz, Unidade Local de Saúde de Lisboa Ocidental, Lisbon, Portugal.
João Vaz AlvesServiço de Doenças Infecciosas e Medicina Tropical, Hospital de Egas Moniz, Unidade Local de Saúde de Lisboa Ocidental, Lisbon, Portugal.
Joana VasconcelosEmergency Response and Biopreparedness Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
João DomingosServiço de Doenças Infecciosas e Medicina Tropical, Hospital de Egas Moniz, Unidade Local de Saúde de Lisboa Ocidental, Lisbon, Portugal.
Sara CasanovaServiço de Doenças Infecciosas e Medicina Tropical, Hospital de Egas Moniz, Unidade Local de Saúde de Lisboa Ocidental, Lisbon, Portugal.
Frederico DuarteServiço de Doenças Infeciosas, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal.
Maria João GonçalvesServiço de Doenças Infeciosas, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal.
Mafalda Brito SalvadorUnidade de Doenças Sexualmente Transmissíveis, Unidade de Cuidados de Saúde Personalizados da Lapa, Unidade Local de Saúde de São José, Lisbon, Portugal.
Mafalda Andresen GuimarãesPPCIRA, Unidade de Tratamento de Imunodeficiência, Hospital de Cascais, Lisboa, Portugal.
Sueila MartinsUL-PPCIRA, Unidade Local de Saúde Trás-os-Montes e Alto Douro, Vila Real, Portugal.
Marvin Silva OliveiraServiço de Patologia Clínica, Unidade Local de Saúde do Tâmega e Sousa, Penafiel, Portugal.
Daniela SantosTechnology and Innovation Unit, Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
Luís VieiraTechnology and Innovation Unit, Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
Maria Sofia NúncioEmergency Response and Biopreparedness Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
Vítor BorgesGenomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
João Paulo GomesGenomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2023, a second wave of the global mpox epidemic, which is mainly affecting men who have sex with men (MSM), was observed in some countries. Herein, we benefited from a large viral sequence sampling (76/121; 63%) and vast epidemiological data to characterise the re-emergence and circulation of the
Indexed as
Disease OutbreaksMonkeypox virusMpox, MonkeypoxPublic HealthAdolescentAdultFemaleForecastingHomosexuality, MaleHumansMaleMiddle AgedPhylogenyPortugalYoung Adulthigh sexual activityMonkeypox virusMSMsecond wavevaccination
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.